Chelsea Bast is a pharmacist who is specialized in Critical Care in Roanoke, Virginia. Patients can reach her at 1906 Belleview Ave Se, Roanoke or contact her on 540-613-9125. Active license number of Chelsea Bast is 0202216764 for Critical Care in Virginia. Chelsea Bast is a licensed pharmacist who has demonstrated specialized knowledge and skill in the delivery of patient care services by pharmacists, as integral members of interprofessional teams, working to ensure the safe and effective use of medications in critically ill patients.
Complete Profile:
Chelsea Bast speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Chelsea Bast
Specialization:
Critical Care
Gender:
Female
Location:
1906 Belleview Ave Se, Roanoke, Virginia, 24014-1838
Phone:
540-613-9125
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Chelsea Bast are as mentioned below.
NPI Number:
1104394170
NPI Enumeration Date:
08 Nov, 2018
NPI Last Update On:
08 Nov, 2018
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Chelsea Bast are as mentioned below.
Specialization
License Number
State
Status
Critical Care
0202216764
Virginia
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
113 Norfolk Ave Sw Unit 8, Roanoke, Virginia
Zip:
24011-1209
Phone Number:
--
Fax Number:
--
Patients can reach Chelsea Bast at 1906 Belleview Ave Se, Roanoke, Virginia or can call on phone at 540-613-9125.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.